The Department of Health has established a dedicated 'unit' focused on "structured projects of engagement with consumer and patient groups."
According to the communiqué from the March meeting of the Department's HTA Consumer Consultative Committee, a new HTA Consumer Evidence and Engagement Unit will be led by Dr Sally Wortley.
The unit will support the committee's work on enhancing consumer input to health technology assessment processes.
"The HTA Consumer Evidence and Engagement Unit will be led by Dr Sally Wortley and will support the work of the HTA CCC as well as develop additional opportunities for consumer and patient impact and involvement across the HTA process," said the communiqué.
PBAC chair Professor Andrew Wilson highlighted Dr Wortley's appointment in response to questions about patient and consumer input at yesterday's PharmaDispatch 2019 conference in Sydney.